Protein-losing Nephropathy in Small Animals

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 1, 2011, Pages 31-62

  Littman, Meryl P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Amyloidosis; Glomerular disease; Glomerulonephritis; Glomerulosclerosis; Proteinuria

Indexed keywords

ACETYLSALICYLIC ACID; ALISKIREN; ALPHA ACTININ 4; ATOPICA; BENAZEPRIL; CD2 ASSOCIATED PROTEIN; CHLORAMBUCIL; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; ENACARD; ENALAPRIL; IMMUNOSUPPRESSIVE AGENT; LAMININ; LAMININ BETA 2; LOSARTAN; LOSARTAN POTASSIUM; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYOSIN IIA; NEPHRIN; OMEGA 3 FATTY ACID; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON 1; PLACEBO; PODOCIN; SPIRONOLACTONE; TELMISARTAN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG; UNINDEXED DRUG; WT1 PROTEIN;

AMYLOIDOSIS; COLLAGEN DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HOMOZYGOSITY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LOW DRUG DOSE; LYME DISEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROALBUMINURIA; NEPHROTIC SYNDROME; NONHUMAN; PHENOTYPE; PODOCYTE; PREVALENCE; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN LOSING NEPHROPATHY; PROTEINURIA; RENAL PROTECTION; REVIEW; SCREENING TEST; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANIMALS; CAT DISEASES; CATS; DISEASE PROGRESSION; DOG DISEASES; DOGS; GENETIC PREDISPOSITION TO DISEASE; KIDNEY DISEASES; PROTEINURIA;

ANIMALIA;

EID: 78651510445     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.09.006     Document Type: Review

References (222)

1. Vaden S.L. Glomerular diseases. Textbook of veterinary internal medicine 2010, 2021-2036. Saunders (Elsevier), St. Louis (MO). 7th edition. S.J. Ettinger, E.C. Feldman (Eds.).
2. Vaden S.L., Brown C.A. Glomerular disease. Kirk's current veterinary therapy XIV 2009, 863-868. Saunders (Elsevier), St. Louis (MO). J.D. Bonagura, D.C. Twedt (Eds.).
3. Grauer G.F. Glomerulonephropathies. Small animal internal medicine 2009, 637-644. Mosby (Elsevier), St. Louis (MO). 4th edition. R.W. Nelson, C.G. Couto (Eds.).
4. Jacob F., Polzin D.J., Osborne C.A., et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005, 226(3):393-400.
5. Wehner A., Hartmann K., Hirschberger J. Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases. Vet Rec 2008, 162(5):141-147.
6. Syme H.M., Markwell P.J., Pfeiffer D., et al. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006, 29(3):528-535.
7. Lees G.E., Brown S.A., Elliott J., et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (Small Animal). J Vet Intern Med 2005, 19(3):377-385.
8. Heska Corporation data. Prevalence of microalbumuminuria in veterinary clinic staff-owned dogs, 2003. Available at: ; Prevalence of microalbuminuria in cats, 2003. Available at: Accessed July 24, 2010. http://www.heska.com/Documents/RenalHealthScreen/erd_datacat.aspx.
9. Vaden S.L., Breitschwerdt E.B., Armstrong P.J., et al. The effects of cyclosporine versus standard care in dogs with naturally occurring glomerulonephritis. J Vet Intern Med 1995, 9(4):259-266.
10. Lowik M.M., Groenen P.J., Levtchenko E.N., et al. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis - a review. Eur J Pediatr 2009, 168(11):1291-1304.
11. Zenker M., Machuca E., Antignac C. Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier. J Mol Med 2009, 87(9):849-857.
12. Russo L.M., Bakris G.L., Comper W.D., et al. Renal handling of albumin: a critical review of basic concepts and perspective. Am J Kidney Dis 2002, 39(5):899-919.
13. Schoeb D.S., Chernin G., Heeringa S.F., et al. Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrol Dial Transplant 2010, 25(9):2970-2976.
14. Caridi G., Trivelli A., Sanna-Cherchi S., et al. Familial forms of nephrotic syndrome. Pediatr Nephrol 2010, 25(2):241-252.
15. Santin S., Garcia-Maset R., Ruiz P., et al. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int 2009, 76(12):1268-1276.
16. Gaskin A.A., Schantz P., Jackson J., et al. Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 2002, 16(1):34-44.
17. Zatelli A., Borgarelli M., Santilli R., et al. Glomerular lesions in dogs infected with Leishmania organisms. Am J Vet Res 2003, 64(5):558-561.
18. Poli A., Abramo F., Mancianti F., et al. Renal involvement in canine leishmaniasis. A light microscopic, immunohistochemical and electron-microscopy study. Nephron 1991, 57(4):444-452.
19. Costa F.A.L., Goto H., Saldanha L.C.B., et al. Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis. Vet Pathol 2003, 49(6):677-684.
20. Breitschwerdt E.B. Immunoproliferative enteropathy of Basenjis. Semin Vet Med Surg (Small Anim) 1992, 7(2):153-161.
21. Bartges J.W. Gee - It's GN: proteinuria. Proceedings of the Atlantic Coast Veterinary Conference 2006, Available at:, Accessed July 14, 2010. http://www.vin.com/Members/Proceedings/Proceedings.plx%3FCID%3DACVC2006%26PID%3Dpr14336%26Print%3D1%26O%3DVIN.
22. Rha J.Y., Labato M.A., Ross L.A., et al. Familial glomerulonephropathy in a litter of beagles. J Am Vet Med Assoc 2000, 216(1):46-50.
23. Bowles M.H., Mosier D.A. Renal amyloidosis in a family of beagles. J Am Vet Med Assoc 1992, 201(4):569-574.
24. Reusch C., Hoerauf A., Lechner J., et al. A new familial glomerulonephropathy in Bernese mountain dogs. Vet Rec 1994, 134(16):411-415.
25. Minkus G., Breuer W., Wanke R., et al. Familial nephropathy in Bernese Mountain Dogs. Vet Pathol 1994, 31(4):421-428.
26. Gerber B., Eichenberger S., Haug K., et al. Association of urine protein excretion and infection with Borrelia burgdorferi sensu lato in Bernese Mountain dogs. Vet J 2009, 182(3):487-488.
27. Gerber B., Haug K., Eichenberger S., et al. Follow up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals?. BMC Vet Res 2009, 5:18.
28. Chandler M.L., Elwood C., Murphy K.F., et al. Juvenile nephropathy in 37 boxer dogs. J Small Anim Pract 2007, 48(12):690-694.
29. Cork L.C., Morris J.M., Olson J.L., et al. Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement. Clin Immunol Immunopathol 1991, 60(3):455-470.
30. Hood J.C., Savige J., Hendtlass A., et al. Bull terrier hereditary nephritis: a model for autosomal dominant Alport syndrome. Kidney Int 1995, 47:758-765.
31. Hood J.C., Robinson W.F., Clark W.F., et al. Proteinuria as an indicator of early renal disease in bull terriers with hereditary nephritis. J Small Anim Pract 1991, 32(5):241-248.
32. Hood J.C., Savige J.A., Dowling J., et al. Ultrastructural appearance of renal and other basement membranes in the bull terrier model of autosomal dominant hereditary nephritis. Am J Kidney Dis 2000, 36(2):378-391.
33. Hood J.C., Dawling J., Bertram J.F., et al. Correlation of histopathological features and renal impairment in autosomal dominant Alport syndrome in Bull terriers. Nephrol Dial Transplant 2002, 17(11):1897-1908.
34. Burrows A.K., Malik R., Hunt G.B., et al. Familial polycystic kidney disease in bull terriers. J Small Anim Pract 1994, 35(7):364-369.
35. O'Leary C.A., MacKay B.M., Malik R., et al. Polycystic kidney disease in Bull Terriers: an autosomal dominant inherited disorder. Aust Vet J 1999, 77(6):361-366.
36. Casal M.L., Dambach D.M., Meister T., et al. Familial glomerulonephropathy in the Bullmastiff. Vet Pathol 2004, 41(4):319-325.
37. Hood J.C., Huxtable C., Naito I., et al. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs. Nephrol Dial Transplant 2002, 17(12):2094-2098.
38. Wilcock B.P., Patterson J.M. Familial glomerulonephritis in Doberman Pinscher dogs. Can Vet J 1979, 20(9):244-249.
39. Picut C.A., Lewis R.M. Juvenile renal disease in the Doberman pinscher: ultrastructural changes of the glomerular basement membrane. J Comp Pathol 1987, 97(5):587-596.
40. Giger U., Werner L.L., Millichamp N.J., et al. Sulfadiazine-induced allergy in six Doberman Pinschers. J Am Vet Med Assoc 1985, 186(5):479-484.
41. Vasilopulos R.J., Mackin A., Lavergne S.N., et al. Nephrotic syndrome associated with administration of sulfadimethoxine/ormetoprim in a dobermann. J Small Anim Pract 2005, 46(5):232-236.
42. Trepanier L.A. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 2004, 27(3):129-138.
43. Lees G.E., Wilson P.D., Helman R.G., et al. Glomerular ultrastructural findings similar to hereditary nephritis in four English cocker spaniels. J Vet Intern Med 1997, 11(2):80-85.
44. Lees G.E., Helman R.G., Homco L.D., et al. Early diagnosis of familial nephropathy in English cocker spaniels. J Am Anim Hosp Assoc 1998, 34(3):189-195.
45. Lees G.E., Helman R.G., Kashtan C.E., et al. A model of autosomal recessive Alport syndrome in English cocker spaniel dogs. Kidney Int 1998, 54(3):706-719.
46. Davidson A.G., Bell R.J., Lees G.E., et al. Genetic cause of autosomal recessive hereditary nephropathy in the English cocker spaniel. J Vet Intern Med 2007, 21(3):394-401.
47. Mason N.J., Day M.J. Renal amyloidosis in related English foxhounds. J Small Anim Pract 1996, 37(6):255-260.
48. Lavoue R., van der Lugt J.J., Day M.J., et al. Progressive juvenile glomerulonephropathy in 16 related French Mastiff (Bordeaux) dogs. J Vet Intern Med 2010, 24(2):314-322.
49. Codner E.C., Caceci T., Saunders G.K., et al. Investigation of glomerular lesions in dogs with acute experimentally induced Ehrlichia canis infection. Am J Vet Res 1992, 53(12):2286-2291.
50. Codner E.C., Maslim W.R. Investigation of renal protein loss in dogs with acute experimentally induced Ehrlichia canis infection. Am J Vet Res 1992, 53(3):294-299.
51. Nyindo M., Huxsoll D.L., Ristic M., et al. Cell-mediated and humoral immune responses of German shepherd dogs and beagles to experimental infection with Ehrlichia canis. Am J Vet Res 1980, 41(2):250-254.
52. de Castro M.B., Machado R.Z., de Aquino L.P., et al. Experimental acute canine monocytic ehrlichiosis: clinicopathological and immunopathological findings. Vet Parasitol 2004, 119(1):73-86.
53. Dambach D.M., Smith C.A., Lewis R.M., et al. Morphologic, immunohistochemical, and ultrastructural characteristics of a distinctive renal lesion in dogs putatively associated with Borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol 1997, 34(2):85-96.
54. Littman M.P., Goldstein R.E., Labato M.A., et al. ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med 2006, 20(2):422-434.
55. Chou J., Wunschmann A., Hodzic E., et al. Detection of Borrelia burdorferi DNA in tissues from dogs with presumptive Lyme borreliosis. J Am Vet Med Assoc 2006, 229(8):1260-1265.
56. Sanders NA. Canine Lyme nephritis. In: Proceedings of the 18th ACVIM Forum. Seattle (WA), May 25--28, 2000. p. 627-8.
57. Goldstein R.E., Cordner A.P., Sandler J.L., et al. Microalbuminuria and comparison of serologic testing for exposure to Borrelia burgdorferi in nonclinical Labrador and Golden Retrievers. J Vet Diagn Invest 2007, 19(3):294-297.
58. Kerlin R.L., Van Winkle T.J. Renal dysplasia in golden retrievers. Vet Pathol 1995, 32(3):327-329.
59. de Morais H.S., DiBartola S.P., Chew D.J. Juvenile renal disease in golden retrievers: 12 cases (1984-1994). J Am Vet Med Assoc 1996, 209(4):792-797.
60. Reilly C.M., Munson L., Bell J.S. Progressive juvenile nephropathy in Gordon Setters. Vet Pathol 2007, 44(5):740.
61. Carpenter J.L., Andelman N.C., Moore F.M., et al. Idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 1988, 25(6):401-407.
62. Hertzke D.M., Cowan L.A., Schoning P., et al. Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 1995, 32(5):451-459.
63. Cowan L.A., Hertzke D.M., Fenwick B.W., et al. Clinical and clinicopathologic abnormalities in greyhounds with cutaneous and renal glomerular vasculopathy: 18 cases (1992-1994). J Am Vet Med Assoc 1997, 210(6):789-793.
64. Bjotvedt G., Hendricks G.M., Brandon T.A. Hemodynamic basis of renal arteriosclerosis in young greyhounds. Lab Anim Sci 1988, 38(1):62-67.
65. Cox M.L., Lees G.E., Kashtan C.E., et al. Genetic cause of X-linked Alport syndrome in a family of domestic dogs. Mamm Genome 2003, 14(6):396-403.
66. Lees G.E., Helman R.G., Kashtan C.E., et al. New form of X-linked dominant hereditary nephritis in dogs. Am J Vet Res 1999, 60(3):373-383.
67. Koeman J.P., Biewenga W.J., Gruys E. Proteinuria associated with glomerulosclerosis and glomerular collagen formation in three Newfoundland dog littermates. Vet Pathol 1994, 31(2):188-193.
68. Finco D.R. Familial renal disease in Norwegian elkhound dogs: physiologic and biochemical examinations. Am J Vet Res 1976, 37(1):87-91.
69. Finco D.R., Duncan J.D., Crowell W.A., et al. Familial renal disease in Norwegian elkhound dogs: morphologic examinations. Am J Vet Res 1977, 38(7):941-947.
70. McKay L.W., Seguin M.A., Ritchey J.W., et al. Juvenile nephropathy in two related Pembroke Welsh corgi puppies. J Small Anim Pract 2004, 45(11):568-571.
71. Cook S.M., Dean D.F., Golden D.L., et al. Renal failure attributable to atrophic glomerulopathy in four related rottweilers. J Am Vet Med Assoc 1993, 202(1):107-109.
72. Zheng K., Thorner P.S., Marrano P., et al. Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc Natl Acad Sci U S A 1994, 91(9):3989-3993.
73. Jansen B., Valli V.E., Thorner P., et al. Samoyed hereditary glomerulonephropathy: serial clinical and laboratory (urine, serum biochemistry and hematology) studies. Can J Vet Res 1987, 51(3):387-393.
74. Lees G.E., Jensen W.A., Simpson D.F., et al. Persistent albuminuria precedes onset of overt proteinuria in male dogs with X-linked hereditary nephropathy. J Vet Intern Med 2002, 16(3):353.
75. Lees G.E., Willard M.D., Dziezyc J. Glomerular proteinuria is rapidly but reversibly increased by short-term prednisone administration in heterozygous (carrier) female dogs with X-linked hereditary nephropathy. J Vet Intern Med 2002, 16(3):352.
76. Chen D., Jefferson B., Harvey S.J., et al. Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model. J Am Soc Nephrol 2003, 14(3):690-698.
77. Grodecki K.M., Gains M.J., Baumal R., et al. Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin-converting enzyme (ACE) inhibitor. J Comp Pathol 1997, 117(3):209-225.
78. Valli V.E., Baumal R., Thorner P., et al. Dietary modification reduces splitting of glomerular basement membranes and delays death due to renal failure in canine X-linked hereditary nephritis. Lab Invest 1991, 65(1):67-73.
79. DiBartola S.P., Tarr M.J., Webb D.M., et al. Familial renal amyloidosis in Chinese Shar Pei dogs. J Am Vet Med Assoc 1990, 197(4):483-487.
80. May C., Hammill J., Bennett D. Chinese Shar Pei fever syndrome: a preliminary report. Vet Rec 1992, 131(25-26):586-587.
81. Rivas A.L., Tintle L., Kimball E.S., et al. A canine febrile disorder associated with elevated interleukin-6. Clin Immunol Immunopathol 1992, 64(1):36-45.
82. Rivas A.L., Tintle L., Meyers-Wallen V., et al. Inheritance of renal amyloidosis in Chinese Shar Pei dogs. J Hered 1993, 84(6):438-442.
83. Johnson K.H., Sletten K., Hayden D.W., et al. AA amyloidosis in Chinese Shar Pei dogs: immunohistochemical and amino acid sequence analysis. Int J Exp Clin Invest 1995, 2(2):92-99.
84. Littman M.P., Dambach D.M., Vaden S.L., et al. Familial protein-losing enteropathy and protein-losing nephropathy in soft-coated wheaten terriers: 222 cases (1983-1997). J Vet Intern Med 2000, 14(1):68-80.
85. Vaden S.L., Hammerberg B., Davenport D.J., et al. Food hypersensitivity reactions in soft-coated wheaten terriers with protein-losing enteropathy or protein-losing nephropathy or both: gastroscopic food sensitivity testing, dietary provocation, and fecal immunoglobulin E. J Vet Intern Med 2000, 14(1):60-67.
86. Vaden S.L., Sellon R.K., Melgarejo L.T., et al. Evaluation of intestinal permeability and gluten sensitivity in soft-coated wheaten terriers with familial protein-losing enteropathy, protein-losing nephropathy, or both. Am J Vet Res 2000, 61(5):518-524.
87. Afrouzian M., Vaden S.L., Harris T., et al. Immune complex mediated proliferative and sclerosing glomerulonephritis in Soft Coated Wheaten Terriers (SCWT): is this an animal model of IgA nephropathy or IgM mesangial nephropathy?. J Am Soc Nephrol 2001, 12:670A.
88. Allenspach K., Lomas B., Wieland B., et al. Evaluation of perinuclear anti-neutrophilic cytoplasmic autoantibodies as an early marker of protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers. Am J Vet Res 2008, 69(10):1301-1304.
89. Vaden S.L., Jensen W., Longhofer S., et al. Longitudinal study of microalbuminuria in soft-coated wheaten terriers. J Vet Intern Med 2001, 15(3):300.
90. Nash A.S., Kelly D.F., Gaskell C.J. Progressive renal disease in soft-coated wheaten terriers: possible familial nephropathy. J Small Anim Pract 1984, 25(8):479-487.
91. Eriksen K., Grondalen J. Familial renal disease in soft-coated wheaten terriers. J Small Anim Pract 1984, 25(8):489-500.
92. Chew D.J., DiBartola S.P., Boyce J.T., et al. Renal amyloidosis in related Abyssinian cats. J Am Vet Med Assoc 1982, 181(2):139-142.
93. DiBartola S.P., Benson M.D., Dwulet F.E., et al. Isolation and characterization of amyloid protein AA in the Abyssinian cat. Lab Invest 1985, 52(5):485-489.
94. DiBartola S.P., Tarr M.J., Benson M.D. Tissue distribution of amyloid deposits in Abyssinian cats with familial amyloidosis. J Comp Pathol 1986, 96(4):387-398.
95. Boyce J.T., DiBartola S.P., Chew D.J., et al. Familial renal amyloidosis in Abyssinian cats. Vet Pathol 1984, 21(1):33-38.
96. Niewold T.A., van der Linde-Sipman J.S., Murphy C., et al. Familial amyloidosis in cats: Siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition. Amyloid 1999, 6(3):205-209.
97. Godfrey D.R., Day M.J. Generalised amyloidosis in two Siamese cats: spontaneous liver haemorrhage and chronic renal failure. J Small Anim Pract 1998, 39(9):442-447.
98. Lees G.E. Familial renal disease in dogs. Textbook of veterinary internal medicine 2010, 2058-2062. Saunders (Elsevier), St. Louis (MO). 7th edition. S.J. Ettinger, E.C. Feldman (Eds.).
99. Pescucci C., Mari F., Longo I., et al. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 2004, 65(5):1598-1603.
100. Herrera G.A., Turbat-Herrera E.A. Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 2010, 134(4):512-531.
101. Kamile J., Yasuno K., Ogihara K., et al. Collagenofibrotic glomerulonephropathy with fibronectin deposition in a dog. Vet Pathol 2009, 46(4):688-692.
102. Kobayashi R., Yasuno K., Ogihara K., et al. Pathological characterization of collagenofibrotic glomerulonephropathy in a young dog. J Vet Med Sci 2009, 71(8):1137-1141.
103. Cavana P., Capucchio M.T., Bovero A., et al. Noncongophilic fibrillary glomerulonephritis in a cat. Vet Pathol 2008, 45(3):347-351.
104. Brown P.J., Skuse A.M., Tappin S.W. Pulmonary haemorrhage and fibrillary glomerulonephritis (pulmonary-renal syndrome) in a dog. Vet Rec 2008, 162(4):486-487.
105. Center S.A., Smith C.A., Wilkinson E., et al. Clinicopathologic, renal immunofluorescent, and light microscopic features of glomerulonephritis in the dog: 41 cases (1975-1985). J Am Vet Med Assoc 1987, 190(1):81-90.
106. Macdougall D.F., Cook T., Steward A.P., et al. Canine chronic renal disease: prevalence and types of glomerulonephritis in the dog. Kidney Int 1986, 29(6):1144-1151.
107. Muller-Peddinghaus R., Trautwein G. Spontaneous glomerulonephritis in dogs. I. Classification and immunopathology. Vet Pathol 1977, 14(1):1-13.
108. Muller-Peddinghaus R., Trautwein G. Spontaneous glomerulonephritis in dogs. II. Correlation of glomerulonephritis with age, chronic interstitial nephritis and extrarenal lesions. Vet Pathol 1977, 14(2):121-127.
109. Koeman J.P., Biewenga W.J., Gruys E. Proteinuria in the dog: a pathomorphological study of 51 proteinuric dogs. Res Vet Sci 1987, 43(3):367-378.
110. Vilafranca M., Wohlsein P., Trautwein G., et al. Histological and immunohistological classification of canine glomerular disease. Zentralbl Veterinarmed A 1994, 41(8):599-610.
111. Biewenga W.J., Gruys E. Proteinuria in the dog: a clinicopathological study in 51 proteinuric dogs. Res Vet Sci 1986, 41(2):257-264.
112. Jaenke R.S., Allen T.A. Membranous nephropathy in the dog. Vet Pathol 1986, 23(6):718-733.
113. Nash A.S., Wright N.G., Spencer A.J., et al. Membranous nephropathy in the cat: a clinical and pathological study. Vet Rec 1979, 105(4):71-77.
114. Wright N.G., Nash A.S., Thompson H., et al. Membranous nephropathy in the cat and dog: a renal biopsy and follow-up study of sixteen cases. Lab Invest 1981, 45(3):269-277.
115. Grauer G.F. Canine glomerulonephritis: new thoughts on proteinuria and treatment. J Small Anim Pract 2005, 46(10):469-478.
116. Cook A.K., Cowgill L.D. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996, 32(4):313-322.
117. Nangaku M., Couser W.G. Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 2005, 9(3):183-191.
118. Asano T., Tsukamoto A., Ohno K., et al. Membranoproliferative glomerulonephritis in a young cat. J Vet Med Sci 2008, 70(12):1373-1375.
119. Breitschwerdt E.B., Maggi R.G., Chomel B.B., et al. Bartonellosis: an emerging infectious disease of zoonotic importance to animals and human beings. J Vet Emerg Crit Care 2010, 20(1):8-30.
120. Margolis G., Forbus W.D., Kerby G.P., et al. Glomerulonephritis occurring in experimental brucellosis in dogs. Am J Pathol 1947, 23(6):983-993.
121. Granick J.L., Armstrong P.J., Bender J.B. Anaplasma phagocytophilum infection in dogs: 34 cases (2000-2007). J Am Vet Med Assoc 2009, 234(12):1559-1565.
122. Pomianowski A., Lew S., Kuleta Z., et al. Peritoneal dialysis in a dog with acute renal failure caused by the infection with Babesia canis. Pol J Natur Sc 2008, 23(1):257-267.
123. Cavalcante L.F.H., Neuwald E.B., Mello F.P., et al. Nephrotic syndrome in dog associated Babesia canis. Acta Scientiae Veterinariae 2006, 34(3):335-338.
124. Camacho A.T., Guitian F.J., Pallas E., et al. Azotemia and mortality among Babesia microti-like infected dogs. J Vet Intern Med 2004, 18(2):141-146.
125. Slade DJ, Lees GE, Berridge BR, et al. Resolution of a proteinuric nephropathy associated with Babesia gibsoni infection in a dog. J Am Anim Hosp Assoc, in press.
126. Kim H.J., Park C., Jung D.I., et al. A case of protein losing nephropathy in a dog infected with canine Babesia gibsoni. Korean J Vet Res 2006, 46(1):77-81.
127. Baneth G., Weigler B. Retrospective case-control study of hepatozoonosis in dogs in Israel. J Vet Intern Med 1997, 11(6):365-370.
128. Macintire D.K., Vincent-Johnson N., Dillon A.R., et al. Hepatozoonosis in dogs: 22 cases (1989-1994). J Am Vet Med Assoc 1997, 210(7):916-922.
129. Quigg R.J., Gaines R., Wakely P.E., et al. Acute glomerulonephritis in a patient with Rocky Mountain Spotted Fever. Am J Kidney Dis 1991, 17(3):339-342.
130. Hervas J., Gomez-Villamandos J.C., Perez J., et al. Focal mesangial-sclerosing glomerulonephritis and acute-spontaneous infectious canine hepatitis; structural, immunohistochemical and subcellular studies. Vet Immunol Immunopathol 1997, 57(1/2):25-32.
131. Glick A.D., Horn R.G., Holscher M. Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasms. Am J Pathol 1978, 92(2):321-332.
132. Poli A., Abramo F., Taccini E., et al. Renal involvement in feline immunodeficiency virus infection: a clinicopathological study. Nephron 1993, 64(2):282-288.
133. Baxter K.J., Levy J.K., Edinboro C.H., et al. Renal disease in cats infected with feline immunodeficiency virus. J Vet Intern Med 2010, 24(3):677.
134. Avila A., Reche A., Kogika M.M., et al. Occurrence of chronic kidney disease in cats naturally infected with immunodeficiency virus. J Vet Intern Med 2010, 24(3):760.
135. Hayashi T., Ishida T., Fujiwara K. Glomerulonephritis associated with feline infectious peritonitis. Nippon Juigaku Zasshi 1982, 44(6):909-916.
136. Grauer G.F., Culham C.A., Cooley A.J., et al. Clinicopathologic and histologic evaluation of Dirofilaria immitis-induced nephropathy in dogs. Am J Trop Med Hyg 1987, 37(3):588-596.
137. Kramer L., Simon F., Tamarozzi F., et al. Is Wolbachia complicating the pathological effects of Dirofilaria immitis infections?. Vet Parasitol 2005, 133(2/3):133-136.
138. Ludders J.W., Grauer G.F., Dubielzig R.R., et al. Renal microcirculatory and correlated histologic changes associated with dirofilariasis in dogs. Am J Vet Res 1988, 49(6):826-830.
139. Grauer G.F., Oberhauser E.B., Basaraba R.J., et al. Development of microalbuminuria in dogs with heartworm disease. J Vet Intern Med 2002, 16(3):352.
140. Casey H.W., Splitter G.A. Membranous glomerulonephritis in dogs infected with Dirofilaria immitis. Vet Pathol 1975, 12(2):111-117.
141. Ruth J. Heterobilharzia americana infection and glomerulonephritis in a dog. J Am Anim Hosp Assoc 2010, 46(3):203-208.
142. Ginel P.J., Camacho S., Lucena R. Anti-histone antibodies in dogs with leishmaniasis and glomerulonephritis. Res Vet Sci 2008, 85(3):510-514.
143. Ortega-Pacheco A., Colin-Flores R.F., Gutierrez-Blanco E., et al. Frequency and type of renal lesions in dogs naturally infected with Leptospira species. Ann N Y Acad Sci 2008, 1149:270-274.
144. Zaragoza C., Barrera R., Centeno F., et al. Characterization of renal damage in canine leptospirosis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting of the urinary proteins. J Comp Pathol 2003, 129(2-3):169-178.
145. Mastrorilli C., Dondi F., Agnoli C., et al. Clinicopathologic features and outcome predictors of Leptospira interrogans Australis serogroup infection in dogs: a retrospective study of 20 cases (2001-2004). J Vet Intern Med 2007, 21(1):3-10.
146. Sykes JE, Hartmann K, Lunn KF, et al. 2010 ACVIM/ISCAID Small Animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. Draft is currently on the ACVIM. Available at: Accessed July 25, 2010, to be published J Vet Intern Med 2011. http://www.acvim.org/websites/acvim/File/Resources/Lepto_consensus_draft_July11_forcomment_2010.pdf.
147. Acierno M.J., Labato M.A., Stern L.C., et al. Serum concentrations of the third component of complement in healthy dogs and dogs with protein-losing nephropathy. Am J Vet Res 2006, 67(7):1105-1109.
148. Harris C.H., Krawiec D.R., Gelberg H.B., et al. Canine IgA glomerulonephropathy. Vet Immunol Immunopathol 1993, 36(1):1-16.
149. Miyauchi Y., Nakayama H., Uchida K., et al. Glomerulopathy with IgA deposition in the dog. J Vet Med Sci 1992, 54(5):969-975.
150. Biewenga W.J., Gruys E., Hendriks H.G. Urinary protein loss in the dog: nephrological study of 29 dogs without signs of renal disease. Res Vet Sci 1982, 33(3):366-374.
151. Vilafranca M., Wohlsein P., Leopold-Temmler B., et al. A canine nephropathy resembling minimal change nephrotic syndrome in man. J Comp Pathol 1993, 109(3):271-280.
152. Sum S.O., Hensel P., Rios L., et al. Drug-induced minimal change nephropathy in a dog. J Vet Intern Med 2010, 24(2):431-435.
153. DiBartola S.P., Tarr M.J., Parker A.T., et al. Clinicopathologic findings in dogs with renal amyloidosis: 59 cases (1976-1986). J Am Vet Med Assoc 1989, 195(3):358-364.
154. DiBartola S.P., Benson M.D. The pathogenesis of reactive systemic amyloidosis. J Vet Intern Med 1989, 3(1):31-41.
155. Pressler B.M., Vaden S.L. Managing renal amyloidosis in dogs and cats. Vet Med 2003, 98(4):320-333.
156. Whittemore J.C., Gill V.L., Jensen W.A., et al. Evaluation of the association between microalbuminuria and the urine albumin-creatinine ratio and systemic disease in dogs. J Am Vet Med Assoc 2006, 229(6):958-963.
157. Whittemore J.C., Miyoshi Z., Jensen W.A., et al. Association of microalbuminuria and the urine albumin-to-creatinine ratio with systemic disease in cats. J Am Vet Med Assoc 2007, 230(8):1165-1169.
158. Grauer G.F., Moore L.E., Smith A.R., et al. Comparison of conventional urine protein test strip method and quantitative ELISA for the detection of canine and feline albuminuria. J Vet Intern Med 2004, 18(3):418-419.
159. Zatelli A., Paltrinieri S., Nizi F., et al. Evaluation of a urine dipstick test for confirmation or exclusion of proteinuria in dogs. Am J Vet Res 2010, 7(2):235-240.
160. Lyon S.D., Sanderson M.W., Vaden S.L., et al. Comparison of urine dipstick, sulfosalicylic acid, urine protein-to-creatinine ratio, and species-specific ELISA methods for detection of albumin in urine samples of cats and dogs. J Am Vet Med Assoc 2010, 236(8):874-879.
161. Welles E.G., Whatley E.M., Hall A.S., et al. Comparison of Multistix PRO dipsticks with other biochemical assays for determining urine protein (UP), urine creatinine (UC), and UP:UC ratio in dogs and cats. Vet Clin Pathol 2006, 35(1):31-36.
162. Kahn M., Fernandes P., Jensen M., et al. Comparison of the Vitros 250 and the IDEXX VetTest chemistry analyzer for urine protein:creatinine ratios in dogs and cats. J Vet Intern Med 2005, 19(3):431.
163. Fernandes P., Kahn M., Yang V., et al. Comparison of methods used for determining urine protein-to-creatinine ratio in dogs and cats. J Vet Intern Med 2005, 19(3):431.
164. Kuwahar Y., Nishii N., Takasu M., et al. Use of urine albumin/creatinine ratio for estimation of proteinuria in cats and dogs. J Vet Med Sci 2008, 70(8):865-867.
165. Beatrice L., Nizi F., Callegari D., et al. Comparison of urine protein-to-creatinine ratio in urine samples collected by cystocentesis versus free catch in dogs. J Am Vet Med Assoc 2010, 236(11):1221-1224.
166. Nabity M.B., Boggess M.M., Kashtan C.E., et al. Day-to-day variation of the urine protein:creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy. J Vet Intern Med 2007, 21(3):425-430.
167. LeVine D.N., Zhang D.W., Harris T., et al. The use of pooled vs. serial urine samples to measure urine protein:creatinine ratios. Vet Clin Pathol 2010, 39(1):53-56.
168. Gary A.T., Cohn L.A., Kerl M.E., et al. The effects of exercise on urinary albumin excretion in dogs. J Vet Intern Med 2004, 18(1):52-55.
169. Rawlinson J.E., Goldstein R.E., Erb H.N., et al. Tracking inflammatory and renal parameters in dogs pre- and post-treatment for periodontal disease. J Vet Intern Med 2005, 19(3):430-431.
170. Prober L.G., Johnson C.A., Olivier N.B., et al. Effect of semen in urine specimens on urine protein concentration determined by means of dipstick analysis. Am J Vet Res 2010, 71(3):288-292.
171. Vaden S.L., Pressler B.M., Lappin M.R., et al. Effects of urinary tract inflammation and sample blood contamination on urine albumin and total protein concentrations in canine urine samples. Vet Clin Pathol 2004, 33(1):14-19.
172. Bagley R.S., Center S.A., Lewis R.M., et al. The effect of experimental cystitis and iatrogenic blood contamination on the urine protein/creatinine ratio in the dog. J Vet Intern Med 1991, 5(2):66-70.
173. Ortega T.M., Feldman E.C., Nelson R.W., et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996, 209(10):1724-1729.
174. Hurley K.G., Vaden S.L. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1998, 212(3):369-373.
175. Mazzi A., Fracassi F., Dondi F., et al. Ratio of urinary protein to creatinine and albumin to creatinine in dogs with diabetes mellitus and hyperadrenocorticism. Vet Res Commun 2008, 32(Suppl 1):S299-S301.
176. Waters C.B., Adams L.G., Scott-Moncrieff J.C., et al. Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs. J Vet Intern Med 1997, 11(3):172-177.
177. Schellenberg S., Mettler M., Gentillini F., et al. The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs. J Vet Intern Med 2008, 22(2):273-281.
178. Bacic A., Kogika M.M., Barbaro K.C., et al. Evaluation of albuminuria and its relationship with blood pressure in dogs with chronic kidney disease. Vet Clin Pathol 2010, 39(2):203-209.
179. Struble A.L., Feldman E.C., Nelson R.W., et al. Systemic hypertension and proteinuria in dogs with diabetes mellitus. J Am Vet Med Assoc 1998, 213(6):822-825.
180. Zini E., Bonfanti U., Zatelli A. Diagnostic relevance of qualitative proteinuria evaluated by use of sodium dodecyl sulphate-agarose gel electrophoresis and comparison with renal histologic findings in dogs. Am J Vet Res 2004, 65(7):964-971.
181. Littman M.P. Diagnosis of infectious diseases of the urinary tract. Nephrology and urology of small animals. Ames (IA) 2011, 241-252. Blackwell. J.W. Bartges, D.J. Polzin (Eds.).
182. Laquaniti A., Bolignano D., Donato V., et al. Alterations in lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment. Kidney Blood Press Res 2010, 33(2):100-110.
183. Brown S., Atkins C., Bagley R., et al. ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007, 21(3):542-558.
184. Finco D.R. Association of systemic hypertension with renal injury in dogs with induced renal failure. J Vet Intern Med 2004, 18(3):289-294.
185. Green R.A., Russo E.A., Greene R.T., et al. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc 1985, 186(5):485-488.
186. Palmer K.G., King L.G., Van Winkle T.J. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J Am Vet Med Assoc 1998, 213(2):220-224.
187. Greco D.S., Green R.A. Coagulation abnormalities associated with thrombosis in a dog with nephrotic syndrome. Compend Cont Educ Pract Vet 1987, 9(6):653-658.
188. Goncalves R., Penderis J., Chang Y.P., et al. Clinical and neurological characteristics of aortic thromboembolism in dogs. J Small Anim Pract 2008, 49(4):178-184.
189. Klosterman E.S., Moore G.E., deBrito Galvao J.F., et al. A case-control study of nephrotic syndrome in dogs: 78 cases. J Vet Intern Med 2010, 24(3):678.
190. Schieppati A., Perna A., Zamora J., et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev 2004, 4:CD004293.
191. Barakat R., Molony D.A., Samuels J.A. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev 2003, 4:CD003965.
192. Cowgill LD. Diagnostic assessment of proteinuric renal disease: the 21st century vision. In: ACVIM Forum Proceedings. 2009. Available at: Accessed October 20, 2010. http://www.vin.com/Members/proceedings/Proceedings.plx?CID=ACVIM2009&Category=&PID=51528&O=VIN.
193. Lees G.E., Berridge B.R. Renal biopsy - when and why. NAVC Clinician's Brief 2009, 7(10):26-28.
194. Lees G.E., Berridge B.R., Clubb F.J. Evaluation of renal biopsy samples. NAVC Clinician's Brief 2009, 7(10):67-69.
195. Lees G.E., Berridge B.R., Cianciolo R.E. Renal biopsy stains. NAVC Clinician's Brief 2010, 8(1):27-30.
196. Lees G.E., Bahr A., Sanders M.H. Performing renal biopsy. NAVC Clinician's Brief 2010, 8(4):67-72.
197. Vaden S.L., Levine J.P., Lees G.E., et al. Renal biopsy: a retrospective study of methods and complications in 283 dogs and 65 cats. J Vet Intern Med 2005, 19(6):794-801.
198. Vaden S.L. Renal biopsy of dogs and cats. Clin Tech Small Anim Pract 2005, 20(1):11-22.
199. Vaden S.L. Renal biopsy: methods and interpretation. Vet Clin North Am Small Anim Pract 2004, 34(4):887-908.
200. Brown S.A., Finco D.R., Brown C.A., et al. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am J Vet Res 2003, 64(3):321-327.
201. Lefebvre H.P., Laroute V., Concordet D., et al. Effects of renal impairment on the disposition of orally administered enalapril, benazepril, and their active metabolites. J Vet Intern Med 1999, 13(1):21-27.
202. Tenhundfeld J., Wefstaedt P., Nolte I.J.A. A randomized controlled clinical trial of the use of benazepril and heparin for the treatment of chronic kidney disease in dogs. J Am Vet Med Assoc 2009, 234(8):1031-1037.
203. Grauer G.F., Greco D.S., Getzy D.M., et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000, 14(5):526-533.
204. Vaden SL. What's on the horizon for management of proteinuria renal diseases? In: ACVIM Forum Proceedings. 2009. Available at: Accessed October 20, 2010. http://www.vin.com/Members/Proceedings/Proceedings.plx?CID=acvim2009&PID=pr51531&O=VIN.
205. Segev G., Fascetti A.J., Weeth L.P., et al. Correction of hyperkalemia in dogs with chronic kidney disease consuming commercial renal diets by potassium-reduced home-prepared diet. J Vet Intern Med 2010, 24(3):546-550.
206. Grauer G.F., Rose B.J., Toolan L.A., et al. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs. Am J Vet Res 1992, 53(9):1631-1635.
207. Rackear D., Feldman B., Farver T., et al. The effect of three different dosages of acetylsalicylic acid on canine platelet aggregation. J Am Anim Hosp Assoc 1988, 24(1):23-26.
208. Shearer L., Kruth S.A., Wood D. Effects of aspirin and clopidogrel on platelet function in healthy dogs. Proceedings of the 19th ECVIM-CA Congress 2009, Available at:, Accessed July 10, 2010. http://www.vin.com/Members/Proceedings/Proceedings.plx%3FCID%3Decvim2009%26PID%3Dpr52275%26O%3DVIN.
209. Longhofer S.L., Frisbie D.D., Johnson H.C., et al. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis. Am J Vet Res 1991, 52(3):480-487.
210. Grauer G.F., Frisbie D.D., Longhofer S.L., et al. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs. Am J Vet Res 1992, 53(5):808-813.
211. Grauer G.F., Frisbie D.D., Snyder P.S., et al. Treatment of membranoproliferative glomerulonephritis and nephrotic syndrome in a dog with a thromboxane synthetase inhibitor. J Vet Intern Med 1992, 6(2):77-81.
212. Smith S.A., Tobias A.H., Jacob K.A., et al. Arterial thromboembolism in cats: acute crisis in 127 cases (1992-2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 2003, 17(1):73-83.
213. Ramsey C.C., Burney D.P., Macintire D.K., et al. Use of streptokinase in four dogs with thrombosis. J Am Vet Med Assoc 1996, 209(4):780-785.
214. Clare A.C., Kraje B.J. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J Am Vet Med Assoc 1998, 212(4):539-543.
215. Brown S.A., Brown C.A., Crowell W.A., et al. Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. J Lab Clin Med 1998, 131(5):447-455.
216. Ahmed M.S., Hou S.H., Battaglia M.C., et al. Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus. Am J Kidney Dis 2007, 50(6):1028-1032.
217. Leehey D.J., Casini T., Massey D. Remission of membranous nephropathy after therapy with Astragalus membranaceus. Am J Kidney Dis 2010, 55(4):772.
218. Mahajan A., Simoni J., Sheather S.J., et al. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 2010, 78(3):303-309.
219. Banyard M.R.C., Hassett R.S. The use of mycophenolate mofetil in the treatment of a case of immune-mediated glomerulonephritis in a dog. Aust Vet Pract 2001, 31(3):103-106.
220. Alchi B., Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol 2010, 25(8):1409-1418.
221. Yagi K., Yanagida H., Sugimoto K., et al. Clinicopathologic features, outcome, and therapeutic interventions in four children with isolated C3 mesangial proliferative glomerulonephritis. Pediatr Nephrol 2005, 20(9):1273-1278.
222. Yokoyama H., Wada T., Zhang W., et al. Advances in apheresis therapy for glomerular diseases. Clin Exp Nephrol 2007, 11(2):122-127.